Bioceres Crop Solutions Corp. · NASDAQ:BIOX

Bioceres Crop Solutions — Q4 2022 Earnings Presentation

21 slides from Bioceres Crop Solutions's earnings presentation, 2022

  1. Slide 1: Fourth Quarter & Full-Year 2022

    Slide 1: Fourth Quarter & Full-Year 2022

    BIOCERES CROP SOLUTIONS FISCAL Fourth Quarter & Full-Year • 02 03 2022 04 FOURTH QUARTER 2022

  2. Slide 2: Disclaimer

    Slide 2: Disclaimer

    BIOCERES CROP SOLUTIONS Disclaimer This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an Financial Information Presentation offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial

  3. Slide 3: Key Business & Financial Highlights

    Slide 3: Key Business & Financial Highlights

    BIOCERES CROP SOLUTIONS Key Record comparable revenues for 4Q22 and FY22, increasing by 44% Business and 62% YoY, respectively. Baseline Adjusted EBITDA1 at $17.7 million for 4Q22 and $61.9 million for the year. & Financial $12.4 million in HB4 Wheat revenues, a 94% increase compared to the Highligh

  4. Slide 4: Record Performance in FY22

    Slide 4: Record Performance in FY22

    BIOCERES CROP SOLUTIONS Record Performance in FY22 Comparable Revenues Baseline Adj. EBITDA1 $ million $ million 319.3 24% 61.9 03 62% 49.9 04 46.5 05 41.3 197.4 174.2 06 148.7 FOURTH QUARTER 2022 FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 ¹ Excluding HB4 pre-launch costs.

  5. Slide 5: HB4 Revenue and Gross Profit Evolution

    Slide 5: HB4 Revenue and Gross Profit Evolution

    BIOCERES CROP SOLUTIONS HB4 Revenue and Gross Profit Evolution Total $2.1M $8.3M $14.4M Gross Margin 45% 42% 51% 04 $12.4M 05 06 07 $6.4M $1.4M FOURTH QUARTER 2022 $1.9M $2.0M $0.7M Comparable Revenues Contributed Goods FY20 FY21 FY22

  6. Slide 6: HB4 Wheat Update

    Slide 6: HB4 Wheat Update

    BIOCERES CROP SOLUTIONS HB4 HB4 Wheat revenues ~2x compared to year ago Current Wheat Season in Argentina Wheat contributed goods number Update Gross Margin increase from Current crop challenged by severe drought in Argentina 42% to 53% Varieties showing good early performance 05 3 new varieties add

  7. Slide 7: HB4 Wheat Downstream

    Slide 7: HB4 Wheat Downstream

    BIOCERES CROP SOLUTIONS HB4 Wheat Downstream 13 new processors onboarded since last quarter, reaching a total of 25. Currently working with 23 new processors to be onboarded in the next few quarters 06 Processing capacity increased 1.5x, reaching 1M tn/year 07 08 09 First wheat flour export to Brazi

  8. Slide 8: HB4 Soy Update

    Slide 8: HB4 Soy Update

    BIOCERES CROP SOLUTIONS HB4 2021/22 season crop harvested. Uneven seed quality and Soy performance across varieties Update Two varieties selected for HB4 4220 HB4 5021 commercial launch in the 2nd Gen Variety 3er Gen Variety upcoming season 07 HB4 program redesigned to accelerate variety positioning

  9. Slide 9: HB4 FY22 Regulatory Update

    Slide 9: HB4 FY22 Regulatory Update

    BIOCERES CROP SOLUTIONS HB4 Approvals FY21 FY22 FY22 Argentina Argentina Regulatory Soy Brazil Brazil Update USA USA Paraguay Paraguay 08 Canada Canada 09 China¹ 10 11 Argentina Argentina Wheat Brazil ¹ Colombia ¹ Australia ² FOURTH QUARTER 2022 New Zealand ² USA ¹ Nigeria ¹ 1 Food & Feed approval 2

  10. Slide 10: ProFarm Integration

    Slide 10: ProFarm Integration

    BIOCERES CROP SOLUTIONS ProFarm Integration Merger completed on July 12th, 2022 – 118 days from announcement Leaders on Integration Process Marrone Bio Innovations rebranded as ProFarm Group 09 On track to deliver cost synergies of $8M 10 11 Commercial Reorganization Matti Tiainen 12 Managing Direct

  11. Slide 11: Revenue Growth

    Slide 11: Revenue Growth

    BIOCERES CROP SOLUTIONS Revenue Growth FY22 total comparable revenues +62% 62% 31.6 319.3 10 25.0 11 42.6 12 22.6 13 197.4 44% 104.1 105.7 72.4 82.2 FOURTH QUARTER 2022 4Q FY21 1Q 2Q 3Q 4Q FY22 $ Million FY21 FY22 Comparable As Reported

  12. Slide 12: Comparable Revenues +44% YoY

    Slide 12: Comparable Revenues +44% YoY

    BIOCERES CROP SOLUTIONS Comparable Revenues +44% YoY Comparable 4Q21 4Q22 Key Drivers by Segment Revenue by 32.9 Third-party products Segment 22.7 +45% HB4 Wheat Micro-beaded fertilizer 104.1 49.7 72.4 42.9 105.7 +16% 82.2 11 21.5 6.8 +215% 12 13 14 Comparable Revenues +62% YoY FY21 FY22 103.9 +77%

  13. Slide 13: 4Q22 Comparable Gross Profit +32% YoY

    Slide 13: 4Q22 Comparable Gross Profit +32% YoY

    BIOCERES CROP SOLUTIONS 4Q22 Comparable Gross Profit +32% YoY Comparable Gross Profit 9.8 1.3 41.4 (4.9) Contribution 36.5 by Segment 31.4 32.7 (1.2) 11% 12 13 (8%) 270% 14 15 Comparable As reported FOURTH QUARTER 2022 4Q21 Crop Seed and Crop 4Q22 IAS 29 4Q22 Protection Integrated Nutrition Products

  14. Slide 14: FY22 Comparable Gross Profit +45% YoY

    Slide 14: FY22 Comparable Gross Profit +45% YoY

    BIOCERES CROP SOLUTIONS FY22 Comparable Gross Profit +45% YoY Comparable Gross Profit 19.2 136.9 (10.4) 126.5 Contribution 12.0 11.5 by Segment 94.2 90.9 61% 13 58% 14 28% 15 16 Comparable As reported FOURTH QUARTER 2022 FY21 Crop Seed and Crop FY22 IAS 29 FY22 Protection Integrated Nutrition Produc

  15. Slide 15: 4Q22 Adjusted EBITDA

    Slide 15: 4Q22 Adjusted EBITDA

    BIOCERES CROP SOLUTIONS 4Q22 Adjusted EBITDA OPEX main variations IAS 29 1.5 HB4 OPEX 2.4 14 Operational growth 3.2 3.8 (7.1) 17.4 17.7 15 0.8 3.2 16 0.6 16.6 0.6 16.6 14.6 14.6 17 V V Adj. EBITDA HB4 Program pre-launch cost FOURTH QUARTER 2022 Adj. Gross Operating JV’s Other Income Adj. Adj. Adj. E

  16. Slide 16: FY22 Adjusted EBITDA

    Slide 16: FY22 Adjusted EBITDA

    BIOCERES CROP SOLUTIONS FY22 Adjusted EBITDA OPEX main variations IAS 29 3.7 HB4 OPEX 5.4 Operational growth 20.5 42.7 (7.1) 15 (29.6) IAS 29 adjustments 16 61.9 0.1 49.9 10.3 Estimated $17.7 million EBITDA 17 1.6 accounting impact of IAS 29 in FY22 48.3 V (2.9) 51.5 48.3 51.5 18 V Adj. EBITDA FOURT

  17. Slide 17: Balance Sheet & Cash Position

    Slide 17: Balance Sheet & Cash Position

    BIOCERES CROP SOLUTIONS Balance Sheet & Cash Position Net Debt 2.61x 2.47x Transactions after quarter close Adj. EBITDA Execution of financing agreements announced in 173.4 165.3 connection with the Marrone Bio Innovations merger: 96.7 16 86.7 • New secured convertible notes due in 2026, bringing 17

  18. Slide 18: Exhibits

    Slide 18: Exhibits

    BIOCERES CROP SOLUTIONS 17 Exhibits 18 19 20 FOURTH QUARTER 2022

  19. Slide 19: Unaudited Consolidated Statement of Comprehensive Income

    Slide 19: Unaudited Consolidated Statement of Comprehensive Income

    BIOCERES CROP SOLUTIONS Unaudited Consolidated Statement of Comprehensive Income Three-month period Three-month period Fiscal year Fiscal year ended 06/30/2022 ended 06/30/2021 ended 06/30/2022 ended 06/30/2021 Total revenue 105,749,320 82,211,113 334,800,936 209,526,177 Cost of sales (69,299,211) (

  20. Slide 20: Unaudited Consolidated Statement of Financial Position

    Slide 20: Unaudited Consolidated Statement of Financial Position

    BIOCERES CROP SOLUTIONS Unaudited Consolidated Statement of Financial Position ASSETS 06/30/2022 06/30/2021 LIABILITIES 06/30/2022 06/30/2021 CURRENT ASSETS CURRENT LIABILITIES Cash and cash equivalents 33,404,416 36,046,113 Trade and other payables 117,674,880 72,091,408 Other financial assets 4,66

  21. Slide 21: Contact Us

    Slide 21: Contact Us

    BIOCERES CROP SOLUTIONS Contact Us Investor Relations Investorrelations@biocerescrops.com (54) 0341 4861100 Investors.biocerescrops.com FOURTH QUARTER 2022

Source: Internet Archive copy of s26.q4cdn.com

More decks from Bioceres Crop Solutions Corp.

All 37 Bioceres Crop Solutions decks